Increased mortality in COVID-19 patients with fungal co- and secondary infections admitted to intensive care or high dependency units in NHS hospitals in England

Andrew M. Borman*, Holly Fountain, Rebecca Guy, Ella Casale, Sarah M. Gerver, Suzanne Elgohari, Colin S. Brown, Susan Hopkins, Victoria J. Chalker, Elizabeth M. Johnson

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

6 Citations (Scopus)

Abstract

Highlights
• Patients with severe COVID-19 disease are at risk of fungal co/secondary infections.
• COVID-associated pulmonary aspergillosis and candidemia are most common.
• We estimate impact of fungal infections on outcome in COVID ICU patients in England.
• Aspergillosis and candidemia independently increase COVID-19-associated mortality.
• Length-of-stay was extended in COVID-19 patients with either fungal infection.
Original languageEnglish
Pages (from-to)579-613
Number of pages35
JournalJournal of Infection
Volume84
Issue number4
Early online date4 Jan 2022
DOIs
Publication statusPublished - 8 Apr 2022

Keywords

  • CAPA
  • COVID-19
  • Fungal secondary infection
  • HDU
  • ICU
  • Length of stay
  • Mortality

Fingerprint

Dive into the research topics of 'Increased mortality in COVID-19 patients with fungal co- and secondary infections admitted to intensive care or high dependency units in NHS hospitals in England'. Together they form a unique fingerprint.

Cite this